Edwards Lifesciences Corporation, the global leader in the science of heart valves, has been approved by FDA USA, to launch its Edwards SAPIEN 3 Trans-catheter.
It its most advanced trans-catheter aortic heart valve – with the Commander Delivery System, for the treatment of high-risk patients.
View the full release here.